TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
416,069
|
429,790
|
304,124 |
| Financial expenses |
14,115
|
30,522
|
10,007 |
| Earnings before taxes |
78,012
|
57,765
|
-6,352 |
| Total assets |
373,262
|
398,207
|
430,499 |
| Current assets |
138,842
|
166,603
|
168,284 |
| Current liabilities |
62,027
|
68,580
|
124,531 |
| Equity capital |
300,135
|
318,618
|
288,888 |
| - share capital |
42,999
|
43,775
|
46,881 |
| Employees (average) | 0 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.4%
|
80.0%
|
67.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
18.7%
|
13.4%
|
-2.1% |
| Return on assets (ROA) |
24.7%
|
22.2%
|
0.8% |
| Current ratio |
223.8%
|
242.9%
|
135.1% |
| Return on equity (ROE) |
26.0%
|
18.1%
|
-2.2% |
| Change turnover |
-6,109
|
145,816
|
12,541 |
| Change turnover % |
-1%
|
51%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.